- Home
- LDI vs CLPT Comparison
LDI vs CLPT Comparison
Compare LDI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LDI | CLPT |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.3M | 554.2M |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | LDI | CLPT |
|---|---|---|
| Price | $1.26 | $18.72 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.0M | 898.4K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $17.58 | $45.67 |
| Revenue Next Year | $13.99 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $1.10 | $8.27 |
| 52 Week High | $5.05 | $30.10 |
Technical Indicators
Market Signals| Indicator | LDI | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 55.80 | 66.92 |
| Support Level | $1.11 | $12.55 |
| Resistance Level | $1.30 | $27.64 |
| Average True Range (ATR) | 0.08 | 1.42 |
| MACD | 0.02 | 0.24 |
| Stochastic Oscillator | 76.47 | 87.96 |
Price Performance
Historical ComparisonAbout LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.